Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de abr de 2011
ID: NCT01303783
Completado
Fase 2
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de sept de 2007
ID: NCT00549770
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-blind, Placebo-controlled, Multi-centre, Multi-national Study to Evaluate the Efficacy and Safety of Oral BAY63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
INTERVENTIONAL
Inicio: 17 de dic de 2008
ID: NCT00810693
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
INTERVENTIONAL
Inicio: 30 de abr de 2025
ID: NCT06952530
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg
INTERVENTIONAL
Inicio: 30 de jun de 2020
ID: NCT04273945
Terminado
ClinicalTrials.gov
International Registry to Assess mEdical Practice With lOngitudinal obseRvation for Treatment of Heart Failure
OBSERVATIONAL
Inicio: 23 de jul de 2014
ID: NCT02595814
Reclutando
Fase 4
ClinicalTrials.gov
Latin America Lipid Optimization After Acute Event in Patients With AthErosclerotic CardiovasculaR DiseaSe and High LDL-C
INTERVENTIONAL
Inicio: 11 de feb de 2025
ID: NCT06501443
Completado
Fase 2
ClinicalTrials.gov
Phase IIb Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled Clinical Trial for the Assessment of Coronary Plaque Changes With RVX000222 as Determined by Intravascular Ultrasound
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01067820
Completado
Fase 4
ClinicalTrials.gov
A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
INTERVENTIONAL
Inicio: 10 de ago de 2020
ID: NCT04502862
Completado
ClinicalTrials.gov
A Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness
OBSERVATIONAL
Inicio: 1 de feb de 2011
ID: NCT01634542
Completado
Fase 4
ClinicalTrials.gov
Multicentric Study to Evaluate the Efficacy and Tolerability of an Innovative Formulation of Benzalkonium Chloride-free Latanoprost in Patients With Primary Open-Angle Glaucoma
INTERVENTIONAL
Inicio: 6 de ene de 2017
ID: NCT03331770
Reclutando
ClinicalTrials.gov
Home Monitoring for the Detection of Subclinical Atrial Fibrillation in Hypertensive Patients at Moderate to High Risk of Developing Arrhythmia. BP/AF MODE Study.
OBSERVATIONAL
Inicio: 1 de mar de 2025
ID: NCT07058831
Completado
Fase 3
ClinicalTrials.gov
Randomized Double Blind Trial to Evaluate the Efficacy and Safety of Dronedarone (400mg BID) Versus Amiodarone (600mg Daily for 28 Days, Then 200mg Daily Thereafter) for at Least 6 Months for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (AF)
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00489736
Desconocido
ClinicalTrials.gov
Retrospective Analysis on the Risk of Cardiovascular (CV) Events in HIV- Infected Subjects From Latin America Treated With a Lopinavir/Ritonavir (LPV/r) Based HAART Regimen vs. an Efavirenz (EFV) Based HAART Regimen
OBSERVATIONAL
Inicio: 1 de sept de 2012
ID: NCT01705873
Reclutando
Fase 2
ClinicalTrials.gov
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
INTERVENTIONAL
Inicio: 1 de may de 2025
ID: NCT06929169
Completado
ClinicalTrials.gov
Xarelto + Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients With Atherosclerosis. A Non-interventional Study
OBSERVATIONAL
Inicio: 13 de nov de 2018
ID: NCT03746275
Completado
Fase 3
ClinicalTrials.gov
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group Study Comparing the Efficacy and Safety of Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de oct de 2005
ID: NCT00219141
Completado
Fase 3
ClinicalTrials.gov
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
INTERVENTIONAL
Inicio: 1 de jun de 2012
ID: NCT01618669
Completado
ClinicalTrials.gov
Maraviroc Switch Vascular Endothelium (VE) Substudy: a Substudy of MARCH
OBSERVATIONAL
Inicio: 1 de jun de 2012
ID: NCT01585753
Terminado
Fase 4
ClinicalTrials.gov
Lipid Efficacy and Effects on HDL-C Metabolism of the Extended Release Niacin/Laropiprant Combination Added to Usual Therapy in Patients With Cardiovascular Disease and Low HDL-C That Did Not Achieve the Optional Very Low LDL-C Goal
INTERVENTIONAL
Inicio: 1 de oct de 2011
ID: NCT01308203
Anterior
1
...
16
17
18
...
434
Siguiente
Filtros